文献速递慢性肾脏病

慢性肾脏病中的早期血管衰老:炎症、维生素K、衰老与基因组损伤的影响

Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

本综述探讨慢性肾脏病(CKD)作为早衰临床模型的特征,聚焦于以血管中膜钙化为标志的加速早期血管衰老(EVA)过程。文章汇总证据指出DNA损伤诱导的细胞衰老和「炎性衰老」可能促进EVA,而NRF2信号通路与维生素K在拮抗氧化应激、DNA损伤、衰老和炎性衰老中起关键作用,可能成为新的治疗靶点。

要点

  • CKD是早衰临床模型,EVA由血管中膜钙化介导,是心血管病和死亡的强预测因子。
  • 现有VC治疗未能证明可预防或逆转CKD患者的VC进展。
  • DNA损伤诱导的细胞衰老和炎性衰老可能促进EVA。

核心结论

  • DNA损伤诱导的细胞衰老和炎性衰老可能在CKD相关加速EVA中起主要作用。
  • NRF2信号通路和维生素K可能通过拮抗氧化应激、DNA损伤、衰老和炎性衰老为EVA提供新治疗靶点。

研究设计与样本

  • 综述文章,讨论CKD背景下衰老与EVA的联系,聚焦NRF2和维生素K在DNA损伤信号、衰老和炎性衰老中的作用。

主要发现

  • CKD是以心血管疾病、持续性尿毒症性炎症、骨质疏松性肌肉萎缩和衰弱为特征的早衰临床模型。
  • 由血管中膜钙化(VC)介导的加速EVA过程是衰老的标志,也是CKD人群心血管发病率和死亡率的强预测因子。
  • 现有VC临床治疗策略和新疗法尚未被证明可预防或逆转CKD患者的VC进展。
  • 越来越多证据表明DNA损伤诱导的细胞衰老和「炎性衰老」可能在很大程度上促进以加速EVA为特征的病理状况。
  • NRF2信号通路和维生素K在拮抗氧化应激、DNA损伤、衰老和炎性衰老中起关键作用。

临床怎么用

  • 当前VC治疗未能证明可预防或逆转CKD患者VC进展,需探索新靶点。
  • NRF2激活和维生素K补充可能作为针对EVA的新型治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic kidney disease (CKD) is a clinical model of premature ageing characterized by cardiovascular disease, persistent uraemic inflammation, osteoporosis muscle wasting and frailty. The accelerated early vascular ageing (EVA) process mediated by medial vascular calcification (VC) is a hallmark of senescence as well as a strong predictor of cardiovascular morbidity and mortality in the CKD population. Current clinical therapeutic strategies and novel treatments for VC have not yet been proven to prevent or reverse VC progression in patients with CKD. Knowledge of the fundamental mechanism underlying EVA is urgently needed to identify and develop novel and efficient therapeutic targets for VC and EVA. An accumulating body of evidence indicates that deoxyribonucleic acid (DNA) damage-induced cellular senescence and 'inflammaging' may largely contribute to such pathological conditions characterized by accelerated EVA. Growing evidence shows that nuclear factor erythroid 2-related factor 2 (NRF2) signalling and vitamin K play a crucial role in counteracting oxidative stress, DNA damage, senescence and inflammaging, whereby NRF2 activation and vitamin K supplementation may provide a novel treatment target for EVA. In this review we discuss the link between senescence and EVA in the context of CKD, with a focus on the role of NRF2 and vitamin K in DNA damage signalling, senescence and inflammaging.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Dai L, Schurgers LJ, Shiels PG, et al. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage. Nephrol Dial Transplant. 2020. PMID: 32162665. doi:10.1093/ndt/gfaa006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。